Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature

Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature

Introduction: Anti-PD1 agents are widely used in the treatment of solid tumors. This has prompted the recognition of a class of immune-related adverse events (irAEs), due to the activation of autoimmune T-cells. Pembrolizumab is an anti-PD1 agent, which has been related to an increased risk of vario...

Full description

Bibliographic Details
Main Authors: Francesco Bruno, Rosa Antonietta Palmiero, Bruno Ferrero, Federica Franchino, Alessia Pellerino, Enrica Milanesi, Riccardo Soffietti, Roberta Rudà
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Neurology
Subjects:
pembrolizumab
anti-PD1 agents
neurological immune-related adverse effects
immune-related neurological complications
autoimmune neuropathy
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.669493/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.669493/full

Similar Items